{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:47:40Z","timestamp":1791179260919,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.pbb.2009.12.010","type":"journal-article","created":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T12:05:34Z","timestamp":1261569934000},"page":"92-100","source":"Crossref","is-referenced-by-count":8,"title":["Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats"],"prefix":"10.1016","volume":"97","author":[{"given":"A.J.","family":"Tallett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2009.12.010_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tips.2008.01.008","article-title":"Anti-obesity drugs and neural circuits of feeding","volume":"29","author":"Adan","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2009.12.010_bib2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/13543784.11.9.1189","article-title":"Anti-obesity drug development","volume":"11","author":"Bays","year":"2002","journal-title":"Exp Opin Investig Drugs"},{"key":"10.1016\/j.pbb.2009.12.010_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(91)90106-Z","article-title":"A peripheral 5-HT1D-like receptor involved in serotonergic induced hindlimb scratching in rats","volume":"194","author":"Berendsen","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib4","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/0014-2999(90)92270-S","article-title":"Possible involvement of 5HT1D receptors in drug-induced hindlimb scratching in rats","volume":"183","author":"Berendsen","year":"1990","journal-title":"European Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib5","first-page":"781","article-title":"Synergy between amylin and cholecystokinin for inhibition of food intake in mice","volume":"81","author":"Bhavsar","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-199809060-00005","article-title":"Serotonin and appetite regulation: implications for the treatment of obesity","volume":"9","author":"Blundell","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2009.12.010_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of \u0394-9 tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague\u2013Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/pr.59.2.2","article-title":"Pharmacological treatment of the overweight patient","volume":"59","author":"Bray","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pbb.2009.12.010_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/1028415031000094264","article-title":"Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins","volume":"6","author":"Casado","year":"2003","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.pbb.2009.12.010_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0165-6147(00)01664-3","article-title":"Pharmacotherapy of obesity: targets and perspectives","volume":"22","author":"Chiesi","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2009.12.010_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(00)00105-4","article-title":"Anti-obesity drugs: a critical review of current therapies and future opportunities","volume":"89","author":"Clapham","year":"2001","journal-title":"Pharmac Ther"},{"key":"10.1016\/j.pbb.2009.12.010_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2125.2001.01294.x","article-title":"Drug treatment of obesity: from past failures to future successes?","volume":"51","author":"Collins","year":"2001","journal-title":"Br J Clin Pharmac"},{"key":"10.1016\/j.pbb.2009.12.010_bib13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","article-title":"Thermogenic effects of sibutramine and its metabolites","volume":"126","author":"Connoley","year":"1999","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pbb.2009.12.010_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in na\u00efve mice","volume":"107","author":"Darmani","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2009.12.010_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.drudis.2008.09.001","article-title":"CB1 receptor antagonism: biological basis for metabolic effects","volume":"13","author":"DiMarzo","year":"2008","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pbb.2009.12.010_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0024-3205(92)90491-7","article-title":"Peripheral 5-carboxamidotryptamine induces hindlimb scratching by stimulating 5-HT1A receptors in rats","volume":"51","author":"Eison","year":"1992","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2009.12.010_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2340\/0001555559505512","article-title":"Pruritis in polycythemia vera: treatment with aspirin and possibility of platelet involvement","volume":"59","author":"Fjellner","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.pbb.2009.12.010_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.289.2.187","article-title":"Years of life lost due to obesity","volume":"289","author":"Fontaine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2009.12.010_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1113\/jphysiol.2008.164152","article-title":"Pharmacological targeting of the serotonergic system for the treatment of obesity","volume":"587","author":"Garfield","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.pbb.2009.12.010_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pbb.2006.03.014","article-title":"Locomotion is the major determinant of sibutramine-induced increase in energy expenditure","volume":"83","author":"Golozoubova","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/oby.2008.461","article-title":"Rational design of a combination medication for the treatment of obesity","volume":"17","author":"Greenway","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.pbb.2009.12.010_bib23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.bjp.0702633","article-title":"Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats","volume":"127","author":"Grignaschi","year":"1999","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1568015033477695","article-title":"The psychopharmacology of appetite: targets for potential anti-obesity agents","volume":"3","author":"Halford","year":"2003","journal-title":"Curr Med Chem: CNS Agents"},{"key":"10.1016\/j.pbb.2009.12.010_bib25","first-page":"387P","article-title":"Effects in the rat of sibutramine on food intake and the behavioural satiety sequence","volume":"114","author":"Halford","year":"1995","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","article-title":"Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake","volume":"61","author":"Halford","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuroscience.2007.02.021","article-title":"Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice","volume":"146","author":"Haring","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2009.12.010_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2009.12.010_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0091-3057(01)00709-2","article-title":"Serotonin 2C receptor agonists and the behavioural satiety sequence in mice","volume":"71","author":"Hewitt","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-200509000-00006","article-title":"Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?","volume":"16","author":"Hill","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0031-9384(03)00066-0","article-title":"Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats","volume":"79","author":"Ishii","year":"2003","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib32","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","article-title":"Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0091-3057(02)00938-3","article-title":"Interactions between the CB1 receptor agonist \u03949-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited","volume":"73","author":"Jarbe","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pbb.2006.08.006","article-title":"Effects of CB1R agonist WIN-55, 212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats","volume":"85","author":"Jarbe","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib35","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopha.2004.09.006","article-title":"Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients","volume":"58","author":"Kaya","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pbb.2009.12.010_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1471-4159.2006.04054.x","article-title":"Cannabinoid\u2013serotonin interactions in alcohol-preferring vs. alcohol-avoiding mice","volume":"99","author":"Kela\u0457","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2009.12.010_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0028-3908(96)00171-2","article-title":"BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2009.12.010_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1248\/bpb.21.224","article-title":"Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor","volume":"21","author":"Kimura","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pbb.2009.12.010_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09540260902782810","article-title":"Cannabinoids and appetite: food craving and food pleasure","volume":"21","author":"Kirkham","year":"2009","journal-title":"Int Rev Psychiat"},{"key":"10.1016\/j.pbb.2009.12.010_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002130000596","article-title":"Synergistic effects of opioid and cannabinoid antagonists on food intake","volume":"153","author":"Kirkham","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2009.12.010_bib41","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/jc.2004-0341","article-title":"Pharmacological approaches to weight reduction: therapeutic targets","volume":"89","author":"Korner","year":"2004","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.pbb.2009.12.010_bib42","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1248\/bpb.31.2143","article-title":"Intracisternal, but not intrathecal, injection of naloxone inhibits cutaneous itch-related response in mice","volume":"31","author":"Kuraishi","year":"2008","journal-title":"Biol Pharmaceut Bull"},{"key":"10.1016\/j.pbb.2009.12.010_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2007.09.022","article-title":"The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons","volume":"578","author":"Lau","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(02)01423-1","article-title":"The discovery and status of sibutramine as an anti-obesity drug","volume":"440","author":"Luque","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib45","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjp.0701980","article-title":"Modulation of \u03949-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat","volume":"124","author":"Malone","year":"1998","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0091-3057(01)00567-6","article-title":"Involvement of somatodendritic 5-HT1A receptors in \u03949-tetrahydrocannabinol-induced hypothermia in the rat","volume":"69","author":"Malone","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","article-title":"Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55, 940 in male rats","volume":"15","author":"Marco","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib48","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1471-4159.2007.04961.x","article-title":"CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A\/C receptors","volume":"103","author":"Mato","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2009.12.010_bib49","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine. A review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2009.12.010_bib50","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.282.16.1519","article-title":"The spread of the obesity epidemic in the United States, 1991\u20131998","volume":"282","author":"Mokdad","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2009.12.010_bib51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/BF00978372","article-title":"Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal \u22069-tetrahydrocannabinol treatments","volume":"18","author":"Molina-Holgado","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pbb.2009.12.010_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2005.08.061","article-title":"Ethanol desensitizes cannabinoid CB1 receptors modulating monoamine synthesis in the rat brain in vivo","volume":"392","author":"Moranta","year":"2006","journal-title":"Neurosci Letts"},{"key":"10.1016\/j.pbb.2009.12.010_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","article-title":"Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors","volume":"361","author":"Nakazi","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib54","series-title":"Tackling obesity in England","author":"National Audit Office","year":"2001"},{"key":"10.1016\/j.pbb.2009.12.010_bib55","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/en.2005-0237","article-title":"Peptide YY3\u201336 and glucagon-like peptide-17\u201336 inhibit food intake additively","volume":"146","author":"Neary","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2009.12.010_bib56","unstructured":"NIH Obesity Research Task Force 2004. http:\/\/www.obesityresearch.nih.gov."},{"key":"10.1016\/j.pbb.2009.12.010_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1467-789x.2000.00020.x","article-title":"An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action","volume":"1","author":"Nisoli","year":"2000","journal-title":"Obesity Revs"},{"key":"10.1016\/j.pbb.2009.12.010_bib58","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of athersclerosis in patients with abdominal obesity and coronary heart disease: the STRADIVARIUS randomised controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2009.12.010_bib59","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.ijo.0802475","article-title":"Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized control trials","volume":"27","author":"Padwal","year":"2003","journal-title":"Int J Obesity"},{"key":"10.1016\/j.pbb.2009.12.010_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2009.12.010_bib61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006","article-title":"Medical hazards of obesity","volume":"119","author":"Pi-Sunyer","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pbb.2009.12.010_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2008.08.012","article-title":"Anandamide effects on 5-HT3 receptors in vivo","volume":"596","author":"Racz","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2005.00164.x","article-title":"Prevalence of obesity in Great Britain","volume":"6","author":"Rennie","year":"2005","journal-title":"Obesity Revs"},{"key":"10.1016\/j.pbb.2009.12.010_bib92","doi-asserted-by":"crossref","unstructured":"Rodgers RJ, Halford JCG, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JRS, et al. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 2001;13:1444\u201352.","DOI":"10.1046\/j.0953-816x.2001.01518.x"},{"key":"10.1016\/j.pbb.2009.12.010_bib64","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1210\/en.2007-0898","article-title":"Combination therapy with amylin and PYY[3\u201336] in obese rodents: anorexigenic synergy and weight loss additivity","volume":"148","author":"Roth","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2009.12.010_bib65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(99)00235-6","article-title":"Anorectic efficacy of the fenfluramine\/phenteramine combination in rats: additivity or synergy","volume":"373","author":"Roth","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib66","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/ijo.2008.91","article-title":"Antiobesity effects of the beta-cell hormone amylin in combination with phenteramine or sibutramine in diety-induced obese rats","volume":"32","author":"Roth","year":"2008","journal-title":"Int J Obesity"},{"key":"10.1016\/j.pbb.2009.12.010_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002130100910","article-title":"Effects of the cannabinoid receptor antagonist SR141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats","volume":"159","author":"Rowland","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2009.12.010_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-4328(96)00066-6","article-title":"Serotonergic control of the organization of feeding and satiety","volume":"73","author":"Simansky","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2009.12.010_bib69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"St\u00e4nder","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.pbb.2009.12.010_bib70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2008.05.020","article-title":"Additive subthreshold dose effects of cannabinoid CB1 receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests","volume":"589","author":"Takahashi","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0b013e3282eff0a9","article-title":"Acute anorectic response to cannabinoid receptor antagonist\/inverse agonist AM 251 in rat: indirect behavioural mediation","volume":"18","author":"Tallett","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-007-0880-2","article-title":"Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats","volume":"195","author":"Tallett","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2009.12.010_bib73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbr.2007.10.005","article-title":"Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food","volume":"187","author":"Tallett","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2009.12.010_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.physbeh.2008.02.009","article-title":"Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching","volume":"94","author":"Tallett","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib75","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pbb.2008.08.007","article-title":"Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats","volume":"91","author":"Tallett","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.physbeh.2009.01.022","article-title":"Night & day: diurnal differences in the behavioural satiety sequence in male rats","volume":"97","author":"Tallett","year":"2009","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbr.2008.11.011","article-title":"Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats","volume":"198","author":"Tallett","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2009.12.010_bib78","doi-asserted-by":"crossref","unstructured":"Tallett AJ, Blundell JE, Rodgers RJ. Sibutramine & naloxone: infra-additive interaction in the regulation of appetite? Behav Brain Res. 2010;174\u201381.","DOI":"10.1016\/j.bbr.2009.10.004"},{"key":"10.1016\/j.pbb.2009.12.010_bib79","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","article-title":"Peripheral extendin-4 and peptide YY3\u201336 synergistically reduce food intake through different mechanisms in mice","volume":"146","author":"Talsania","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2009.12.010_bib80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.regpep.2005.09.025","article-title":"Effects of amylin on feeding of goldfish: interactions with CCK","volume":"133","author":"Thavanathan","year":"2006","journal-title":"Regulat Peptides"},{"key":"10.1016\/j.pbb.2009.12.010_bib81","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.pbb.2009.12.010_bib82","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","volume":"46","author":"Uriguen","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2009.12.010_bib83","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2009.12.010_bib84","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.physbeh.2007.11.012","article-title":"Therapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome","volume":"93","author":"Vemuri","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib85","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/jpet.107.131771","article-title":"Effects of a cannabinoid1 receptor antagonist and serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice","volume":"325","author":"Ward","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2009.12.010_bib86","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0091-3057(94)00316-B","article-title":"Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats","volume":"50","author":"Wellman","year":"1995","journal-title":"Pharamcol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib87","unstructured":"Weiss SM. Pharmacological and behavioural examination of the defensive reactions of laboratory mice to the calls of the Tawny owl. PhD thesis, 1995, School of Psychology, University of Leeds."},{"key":"10.1016\/j.pbb.2009.12.010_bib88","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s000110050213","article-title":"Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch","volume":"46","author":"Weisshaar","year":"1997","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pbb.2009.12.010_bib89","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0149-7634(86)90021-7","article-title":"Approaches to the study of drug interactions in behavioral pharmacology","volume":"10","author":"Wessinger","year":"1986","journal-title":"Neurosci Biobehav Revs"},{"key":"10.1016\/j.pbb.2009.12.010_bib90","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0091-3057(01)00694-3","article-title":"Reversal of \u03949-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine","volume":"71","author":"Williams","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.12.010_bib91","series-title":"Report of a WHO consultation. WHO Technical Report Series No. 84","article-title":"Obesity: preventing and managing the global epidemic","author":"World Health Organisation","year":"2000"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709003517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709003517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T16:55:31Z","timestamp":1711040131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305709003517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0091305709003517"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2009.12.010","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}